Receptors, Tumor Necrosis Factor

"Receptors, Tumor Necrosis Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.

Descriptor ID	D018124
MeSH Number(s)	D12.776.543.750.705.852.760
Concept/Terms	Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor Receptors, Cachectin Tumor Necrosis Factor Receptors TNF Receptor Receptor, TNF TNF Receptors Tumor Necrosis Factor Receptor Cachectin Receptors Receptors, TNF

Below are MeSH descriptors whose meaning is more general than "Receptors, Tumor Necrosis Factor".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Tumor Necrosis Factor [D12.776.543.750.705.852.760]

Below are MeSH descriptors whose meaning is related to "Receptors, Tumor Necrosis Factor".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Tumor Necrosis Factor".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Tumor Necrosis Factor" by people in this website by year, and whether "Receptors, Tumor Necrosis Factor" was a major or minor topic of these publications.

Bar chart showing 46 publications over 19 distinct years, with a maximum of 6 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1999	0	1	1
2000	2	2	4
2001	1	0	1
2002	1	3	4
2003	0	4	4
2004	0	4	4
2005	0	1	1
2006	0	1	1
2007	0	2	2
2008	2	1	3
2009	0	5	5
2010	0	1	1
2012	2	4	6
2013	1	1	2
2014	2	1	3
2016	0	1	1
2018	0	1	1

Below are the most recent publications written about "Receptors, Tumor Necrosis Factor" by people in Profiles.

Hirako IC, Assis PA, Hojo-Souza NS, Reed G, Nakaya H, Golenbock DT, Coimbra RS, Gazzinelli RT. Daily Rhythms of TNFa Expression and Food Intake Regulate Synchrony of Plasmodium Stages with the Host Circadian Cycle. Cell Host Microbe. 2018 06 13; 23(6):796-808.e6.

View in: PubMed
Lin B, Ciecko AE, MacKinney E, Serreze DV, Chen YG. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice. Immunogenetics. 2017 03; 69(3):193-198.

View in: PubMed
Xing Q, Yu Q, Dou H, Wang J, Li R, Ning X, Wang R, Wang S, Zhang L, Hu X, Bao Z. Genome-wide identification, characterization and expression analyses of two TNFRs in Yesso scallop (Patinopecten yessoensis) provide insight into the disparity of responses to bacterial infections and heat stress in bivalves. Fish Shellfish Immunol. 2016 May; 52:44-56.

View in: PubMed
Whitsett TG, Fortin Ensign SP, Dhruv HD, Inge LJ, Kurywchak P, Wolf KK, LoBello J, Kingsley CB, Allen JW, Weiss GJ, Tran NL. FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion. Clin Exp Metastasis. 2014 Aug; 31(6):613-23.

View in: PubMed
Wilson NS, Duewell P, Yang B, Li Y, Marsters S, Koernig S, Latz E, Maraskovsky E, Morelli AB, Schnurr M, Ashkenazi A. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant. J Immunol. 2014 Apr 01; 192(7):3259-68.

View in: PubMed
Whitsett TG, Mathews IT, Cardone MH, Lena RJ, Pierceall WE, Bittner M, Sima C, LoBello J, Weiss GJ, Tran NL. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response. Mol Cancer Res. 2014 Apr; 12(4):550-9.

View in: PubMed
Smolen JS, Kay J, Matteson EL, Landew? R, Hsia EC, Xu S, Zhou Y, Doyle MK. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study. Ann Rheum Dis. 2014 Oct; 73(10):1811-8.

View in: PubMed
Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. IL-1? promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol. 2013 Apr 15; 190(8):4196-204.

View in: PubMed
Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, Griffin MR, Solomon DH, Saag KG, Lewis JD. Association between anti-TNF-a therapy and all-cause mortality. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1311-20.

View in: PubMed
Vine K, Votava HJ, Smith BL. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept. Cutis. 2012 Sep; 90(3):132-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals